CG Oncology Insider Sold Shares Worth $23,000,089, According to a Recent SEC Filing
CG Oncology(CGON.US) Director Sells US$23 Million in Common Stock
$CG Oncology(CGON.US)$ Director Song Hong Fang sold 650.46K shares of common stock on Aug 29, 2024 at an average price of $35.36 for a total value of $23 million.Source: Announcement What is
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Form 144 | CG Oncology(CGON.US) Director Proposes to Sell 15 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 29, $CG Oncology(CGON.US)$ Director Unique Diamond Investments Ltd intends to sell 424.21K shares of its common stock on Aug 29, with a total market value of
Form 144 | CG Oncology(CGON.US) Director Proposes to Sell 8 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 29, $CG Oncology(CGON.US)$ Director Charming Jade Ltd intends to sell 226.25K shares of its common stock on Aug 29, with a total market value of approximately $8 million.
We're Not Very Worried About CG Oncology's (NASDAQ:CGON) Cash Burn Rate
Roth Starts CG Oncology at Buy, Cites Anticipated FDA Filing
CG Oncology Price Target Announced at $65.00/Share by Roth MKM
CG Oncology Initiated at Buy by Roth MKM
Roth MKM Initiates Coverage On CG Oncology With Buy Rating, Announces Price Target of $65
CG Oncology Analyst Ratings
Bullish CG Oncology Insiders Loaded Up On US$5.06m Of Stock
Morgan Stanley Keeps Their Buy Rating on CG Oncology, Inc. (CGON)
CG Oncology, Inc. Reports Q2 Results
Buy Rating for CG Oncology: Promising CG0070 Data Signals Strong Market Potential
Analysts' Opinions Are Mixed on These NA Stocks: Solventum Corporation (SOLV) and CG Oncology, Inc. (CGON)
CG Oncology Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results.
CG Oncology Q2 2024 Adj EPS $(0.28) Beats $(0.41) Estimate
CG Oncology 2Q Research and Development Expenses $18.5M >CGON
CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates